A booster shot of the BioNTech/Pfizer vaccine is 95.6 per cent effective against Covid-19 compared with those receiving two shots and a placebo, the companies said on Thursday, citing preliminary results from the first randomised, controlled trial on boosters.
Ugur Sahin, the head of BioNTech, said the “important data” added to the body of evidence suggesting that a booster dose could help “protect a broad population of people from this virus and its variants”.
He added: “Based on these findings we believe that, in addition to broad global access to vaccines for everyone, booster vaccinations could play an important role in sustaining pandemic containment and a return to normalcy.”
您已閱讀29%（690字），剩余71%（1731字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。